HELX.US Franklin Genomic Advancements ETF

ETF Healthcare Equity Franklin Templeton, Inc USA Stocks
- USD
No recent price
Total assets
34.8M
Expense ratio
0.50%
Dividend yield
0.32%
1-year return
+25.36%
Holdings
65
Since
2020

Fund data as reported by the issuer, updated Nov 15, 2026. Total assets are in the fund's base currency.

What does HELX.US invest in?

  • Mostly US stocks (94.0%)
  • Largest sector: Healthcare (96.9%)
  • Largest region: North America (94.1%)
  • Top 3 holdings: 21.9% of the fund

Asset allocation

  • US stocks 94.0%
  • Non-US stocks 4.8%
  • Cash 0.1%

Top holdings

All holdings, sectors and regions

Franklin Genomic Advancements ETF performance

Sharpe ratio 0.84
This year
+20.30%
1 year
+25.36%
3 years
+18.63%
5 years
-2.59%

Volatility 19.5% over 1 year and 19.8% over 3 years. Moderate, similar to a broad stock index.

Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers

HELX.US price

Prices on the chart can differ slightly from the closing prices StockSummer shows.

About Franklin Genomic Advancements ETF

Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.

Full fund profile